EMEA-000611-PIP01-09 - paediatric investigation plan
Pegaptanib sodium
PIP
Human
Pfizer Global Research & Development
E-mail: PIP_Enquiries@pfizer.com
Country: United Kingdom
Phone: +44 13046446607
Fax: +44 1304646607